The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and outcome.
E. Castro
No relevant relationships to disclose
C. L. Goh
No relevant relationships to disclose
D. Olmos
No relevant relationships to disclose
D. Leongamornlert
No relevant relationships to disclose
E. Saunders
No relevant relationships to disclose
M. Tymrakiewicz
No relevant relationships to disclose
N. Mahmud
No relevant relationships to disclose
T. Dadaev
No relevant relationships to disclose
K. Govindasami
No relevant relationships to disclose
M. Guy
No relevant relationships to disclose
L. OBrien
No relevant relationships to disclose
E. Sawyer
No relevant relationships to disclose
A. Hall
No relevant relationships to disclose
R. Wilkinson
No relevant relationships to disclose
Z. Kote-Jarai
No relevant relationships to disclose
R. A. Eeles
No relevant relationships to disclose